Merrimack Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.03.23	Pre-market Movers: EAR, OPRX, INBS, CS, AGBA… (RTTNews)
09.11.22	Pre-market Movers: MACK, IXHL, UPST, CARG, ELBM… (RTTNews)
03.08.22	Merrimack: Ipsen's Phase 3 Trial Of Onivyde Fails To Meet Primary Endpoint (RTTNews)
07.12.20	Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) (RTTNews)
03.12.20	Pre-market Movers In Healthcare Sector: OMER, ITRM, CLSD, CDMO, ACOR… (RTTNews)
05.04.19	MACK Halts MM-310 Study, VKTX On Watch, NAII Hits New High (RTTNews)
22.10.18	FDA Extends Date On BMY's SBLA, Genmab Meets Phase 3 Goals, NCNA, LPTX On Watch (RTTNews)
19.10.18	Merrimack Discontinues Phase 2 SHERLOC Study Of MM-121 In Patients With NSCLC (RTTNews)
26.06.18	FDA Approves 1st Cannabis-Based Drug, TECH Opens Wallet Again, MACK, SPHS Plunge (RTTNews)
14.06.18	GALT Vaults As NASH Research Sparks Interest, MDGL Abuzz, MACK Awaits Data (RTTNews)
29.05.18	Merrimack to Present at the 2018 American Society of Clinical Oncology Annual Meeting (PR Newswire)
08.05.18	Merrimack Reports First Quarter 2018 Financial Results (PR Newswire)
01.05.18	Merrimack Announces Timing of First Quarter 2018 Investor Conference Call (PR Newswire)
09.04.18	Merrimack to Present Preclinical Data at the 2018 American Association for Cancer Research Annual Meeting (PR Newswire)
12.03.18	Merrimack Provides Business Update and Reports 2017 Financial Results (PR Newswire)
12.03.18	Merrimack Strengthens SHERLOC Study of MM-121 in Non-small Cell Lung Cancer (PR Newswire)
05.03.18	Merrimack Announces Timing of Full Year 2017 Investor Conference Call and Presentation at the Cowen Health Care Conference (PR Newswire)
26.02.18	Merrimack Doses First Patient in Randomized Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer (PR Newswire)
20.02.18	Merrimack Announces Formation of New Scientific Advisory Board with Extensive Expertise in Precision Oncology (PR Newswire)
15.02.18	Merrimack to Present at the 2018 RBC Capital Markets Global Healthcare Conference (PR Newswire)
30.11.17	Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors (PR Newswire)
14.11.17	Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team (PR Newswire)
08.11.17	Merrimack Reports Third Quarter 2017 Financial Results (PR Newswire)
01.11.17	Merrimack Announces Timing of Third Quarter 2017 Investor Conference Call (PR Newswire)
30.10.17	Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-small Cell Lung Cancer (PR Newswire)
12.10.17	AERI Faces D-Day, PTI To Report Data In Q4, MACK Makes Peace, MNKD Pulls Back (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	537.20	1.17 %	K V
Part Grp Hldg	1’260.00	0.72 %	K V
Roche Hldg G	252.70	0.52 %	K V
Novartis	92.29	0.39 %	K V
Alcon	77.90	0.36 %	K V
Swiss Life Hldg	716.40	-0.42 %	K V
ABB	49.26	-0.57 %	K V
UBS Group	27.60	-0.58 %	K V
Sika	226.40	-0.96 %	K V
Logitech Intl	70.50	-2.06 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Merrimack Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten